{
    "SPADE_N_13816": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13816",
            "Peptide Name": "Hm-AMP8 (Leu-rich; predicted AMPs, UCLL1)",
            "Source": "leech metagenome, leech, annelid, invertebrates,animals",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "RAVIYKIPYNAIASRWIIAPKKC",
            "Sequence Length": 23,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2675.24,
            "PI": 10.19,
            "Hydrophobicity": 0.2,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Ekaterina N.Grafskaia, Elizaveta R. Pavlova, Ivan A. Latsis, Maja V. Malakhova, Dmitrii V. Ivchenkov, Pavel V. Bashkirov, Erik F. Kot, Konstantin S. Mineev, Alexander S. Arseniev, Dmitry V. Klinov, Vassili N. Lazarev. 2022",
                    "Reference": "Materials & Design 2022; 224: 111364.ScienceDirect",
                    "Title": "Non-toxic antimicrobial peptide Hm-AMP2 from leech metagenome proteins identified by the gradient-boosting approach"
                }
            ],
            "Frequent Amino Acids": "IAK",
            "Absent Amino Acids": "DEFGHLMOQTU",
            "Basic Residues": 5,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 15,
            "Polar Residues": 15,
            "Positive Residues": 5,
            "Negative Residues": 0,
            "Net Charge": 5,
            "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (37.93%) toBrevinin-1GHdL:27%; I=G=F=13%; R: 20%. GRAVY: 0.204; Mol Wt: 2675.276; Mol formula: C126H206N33O28S1; mol ex Coeff:  8592.5.Activity: Active against Gram+ B. subtilis 168HT (MIC 12 uM), S.aureus ST 88 (MIC >100 uM), S. hemolyticus 527 (MIC 47.8 uM), M. smegmatis (MIC 47.8 uM), Gram- E. coli MG1655 (MIC 23.9 uM), K.pneumonia 148 (MIC >100 uM), K.pneumonia 50 (MIC >100 uM), K.pneumonia â€™18-3 (MIC >100 uM), K.pneumonia 231 (MIC >100 uM).Toxicity: little hemo.lytic to human RBC (HC50 >200 uM); mouse fibroblasts McCoy (LC50 >100 uM), MeWo (LC50 >100 uM), Primary fibroblasts (LC50 100 uM), human karatinocytes HaCaT (LC50 100 uM), and mouse macrophages RAW 264.7 (LC50 >100 uM). Seq provided by Ekaterina N.Grafskaia 11/2022.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_25091",
                    "Similarity": 1.0,
                    "Sequence": "RAVIYKIPYNAIASRWIIAPKKC"
                },
                {
                    "SPADE_ID": "SPADE_UN_05242",
                    "Similarity": 0.8888888888888888,
                    "Sequence": "RIYKIRWII"
                }
            ]
        }
    }
}